News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Dana-Farber Cancer Institute
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
Study Finds Tarceva Benefits Older Lung Cancer Patients
October 19, 2005
·
1 min read
Scientists Shut Off Leukemia Gene In Mice
October 19, 2005
·
1 min read
Cloning Experiment Shows Cancer Reversible
October 19, 2005
·
1 min read
Malignant Cancer Cells Generate Mice Through Cloning
October 19, 2005
·
1 min read
Master Blood Cell Gene Identified
October 19, 2005
·
1 min read
Optimizing Protein’s “Death Domain” Halts Leukemia In Laboratory Study
October 19, 2005
·
1 min read
Drug Development
Monkey Protein Fights HIV From Inside Cells
October 19, 2005
·
1 min read
Biotech Beach
Scientists Find Gene That Blocks HIV; Monkey’s Protein Prevents HIV
October 19, 2005
·
1 min read
Genetown
Novel Combination Overcomes Drug-Resistant Myeloma Cells
October 19, 2005
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 14, 2026
·
13 min read
Press Releases
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
April 20, 2026
·
6 min read
Press Releases
Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma
March 9, 2026
·
6 min read
Press Releases
INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
March 4, 2026
·
13 min read
Press Releases
TAG1 Announces Strategic Collaboration to Advance Targeted Alpha Therapies
March 2, 2026
·
3 min read
Press Releases
CALQUENCE® plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukemia in the 1st-line setting
February 20, 2026
·
15 min read
Press Releases
4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer
January 23, 2026
·
4 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
December 16, 2025
·
19 min read
Press Releases
ENHERTU® Plus Pertuzumab Approved in the U.S. as First New Treatment in More Than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
December 16, 2025
·
19 min read
Press Releases
Pierre Fabre Pharmaceuticals Announces Updated Phase 3 Tabelecleucel Data at American Society of Hematology Meeting in Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
December 8, 2025
·
7 min read
